Tobias Nyffenegger

A novel approach to treat in-stent restenosis: 6- and 12-month results using the everolimus-eluting bioresorbable vascular scaffold.

R. Kobza, F. Cuculi, S. Toggweiler, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors.

A. Schmermund, S. Cook, H. Eggebrecht, 2016, Journal of the American College of Cardiology.

Reply: Bioresorbable Scaffold Thrombosis: Why BRS Size Matters.

A. Schmermund, S. Cook, H. Eggebrecht, 2016, Journal of the American College of Cardiology.

First time description of early lead failure of the Linox Smart lead compared to other contemporary high-voltage leads

R. Kobza, B. Berte, S. Toggweiler, 2018, Journal of Interventional Cardiac Electrophysiology.